- 全部删除
您的购物车当前为空
ESI-08 是 EPAC2 的有效拮抗剂,IC50 为 8.4 μM。 ESI-08 特异性阻断 cAMP 诱导的 EPAC 活化,但不阻断 cAMP 介导的 PKA 活化。


为众多的药物研发团队赋能,
让新药发现更简单!
ESI-08 是 EPAC2 的有效拮抗剂,IC50 为 8.4 μM。 ESI-08 特异性阻断 cAMP 诱导的 EPAC 活化,但不阻断 cAMP 介导的 PKA 活化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 469 | In stock | |
| 5 mg | ¥ 997 | In stock | |
| 10 mg | ¥ 1,850 | In stock | |
| 25 mg | ¥ 3,130 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 868 | In stock |
ESI-08 相关产品
| 产品描述 | ESI-08 is an effective antagonist of EPAC2 with an IC50 of 8.4 μM. ESI-08 selectively blocks cAMP-induced EPAC activation but not cAMP-mediated PKA activation. |
| 靶点活性 | EPAC2:8.4 μM |
| 体外活性 | ESI-08 (25 μM) does not alter cAMP-induced type I and II PKA holoenzymes activation while H89, a selective PKA inhibitor, blocked the type I or II PKA activities completely[1]. |
| 分子量 | 353.48 |
| 分子式 | C20H23N3OS |
| CAS No. | 301177-43-5 |
| Smiles | Cc1ccc(C)c(CSc2nc(C3CCCCC3)c(C#N)c(=O)[nH]2)c1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (141.45 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容